PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
0.9550
0.00 (0.00%)
Jun 22, 2026, 12:23 PM EDT - Market open
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $53.3 million as of June 22, 2026. Its market cap has decreased by -25.25% in one year.
Market Cap
53.30M
Enterprise Value
46.79M
1-Year Change
-25.25%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since March 18, 2019, PDS Biotechnology's market cap has increased from $45.51M to $53.30M, an increase of 17.12%. That is a compound annual growth rate of 2.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 53.30M | 26.54% |
| Dec 31, 2025 | 42.12M | -30.92% |
| Dec 31, 2024 | 60.98M | -60.56% |
| Dec 29, 2023 | 154.61M | -58.92% |
| Dec 30, 2022 | 376.31M | 63.37% |
| Dec 31, 2021 | 230.35M | 383.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Context Therapeutics | 58.06M |
| Eloxx Pharmaceuticals | 56.43M |
| Immutep | 54.76M |
| Impact BioMedical | 54.15M |
| Xilio Therapeutics | 52.59M |
| Dogwood Therapeutics | 52.13M |
| Instil Bio | 50.86M |
| Radiopharm Theranostics | 49.70M |